THE Australian Dental Industry
Association is pushing the TGA to
adopt recommendations from a
recent Senate inquiry to increase
the amount of information
provided to patients about the
source of their dental laboratory work.
“ADIA has made formal
representations to the TGA,
requesting that the regulator adopt
a Senate committee recommendation
to consider if the approach used in
the UK of requiring a statement of
manufacture to be provided to
patients, and retained by the dental
practitioner, has merit,” said Troy
Williams, ADIA CEO.
According to AIDA, this statement
would include the name and
address of the manufacturer and a
statement that the device in
question conforms to the essential
principles set out in the regulatory
framework administered by the TGA.The above article was sent to subscribers in Pharmacy Daily's issue from 20 Nov 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Nov 12
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.